Centerpoint Advisors’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1K Hold
350
﹤0.01% 382
2025
Q1
$1K Hold
350
﹤0.01% 380
2024
Q4
$1K Hold
350
﹤0.01% 443
2024
Q3
$1K Hold
350
﹤0.01% 461
2024
Q2
$1K Buy
+350
New +$1K ﹤0.01% 431